1422052-19-4

Basic information

• Product Name: (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonic acid
• Synonyms: (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonic acid
• CAS NO: 1422052-19-4
• Molecular Weight: 589.644
• Mol File: 1422052-19-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonic acid(1422052-19-4)
• EPA Substance Registry System: (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonic acid(1422052-19-4)

Safety Data

• Hazardous Substances Data: 1422052-19-4(Hazardous Substances Data)

Upstream product

• 1190309-71-7 3-bromo-5-fluoro-1H-pyrrolo-[2,3-b]pyridine 
• 98-59-9 p-toluenesulfonyl chloride 
• 1417421-99-8 3-bromo-5-fluoro-1-(p-toluenesulfonyl)-1H-pyrrolo[2,3-b]pyridine 
• 112245-13-3 (S)-tert-leucinol 
• 1259279-57-6 5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(p-toluenesulfonyl)-1H-pyrrolo[2,3-b]pyridine 
• 1422052-18-3 (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutyl ethanethiolate 
• 1422052-17-2 (S)-2-((5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-yl)amino)-3,3-dimethylbutyl methanesulfonate 
• 1422052-16-1 (S)-5-fluoro-2-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-((1-hydroxy-3,3-dimethylbutan-2-yl)amino)nicotinonitrile 
• 1309371-71-8 2-chloro-5,6-difluoropyridine-3-carbonitrile 
• 1422052-15-0 (S)-2-chloro-5-fluoro-6-((1-hydroxy-3,3-dimethylbutan-2-yl)amino)nicotinonitrile 

Downstream Products

• 1422052-20-7 (S)-2-(5-cyano-3-fluoro-6-(5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridin-2-yl)amino)-3,3-dimethylbutane-1-sulfonyl chloride 

Relevant articles and documents

INHIBITORS OF INFLUENZA VIRUSES REPLICATION

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.